Medical Industry Feature: Should You Be Looking at NIPT & Carrier Screening Differently?

Be part of the knowledge.

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Should You Be Looking at NIPT & Carrier Screening Differently?

Should You Be Looking at NIPT & Carrier Screening Differently?
Prenatal genetic testing options and important factors for Healthcare Professionals to consider when screening pregnant patients.
  • Sponsored by

  • Overview

    There are numerous options for pregnancy screening, making the decision of what type of genetic testing to offer your patients more complex.  On today’s program, Dr. Justin Brewer will discuss the most important factors for healthcare professionals to consider when screening their pregnant patients. The focus is on non-invasive prenatal testing and carrier screening panels.

    Dr. Justin Brewer is a practicing OB/GYN and Maternal-Fetal Medicine Specialist at North Mississippi Medical Center in Tupelo, Mississippi.  Dr. Brewer is a professional member of the American College of Obstetrics and Gynecology, the Society of Maternal-Fetal Medicine, the American Institute for Ultrasound and Medicine and the Mississippi State Medical Association. 

    The Harmony Prenatal Test was developed by Ariosa Diagnostics, a CLIA-certified laboratory. As with other lab-developed tests, it has not been cleared or approved by the FDA and is not available for sale as an IVD in the US. Non-invasive prenatal testing (NIPT) based on cell-free DNA analysis is not diagnostic; results should be confirmed by diagnostic testing.

Facebook Comments

You must be in to display playlists.

Get a Dose of ReachMD in Your Inbox
and Practice Smarter Medicine

Stay current with the best in medical education.